echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The traditional pharmaceutical industry needs to be upgraded to the transformation and upgrading of intelligent manufacturing to achieve quality and efficiency gains.

    The traditional pharmaceutical industry needs to be upgraded to the transformation and upgrading of intelligent manufacturing to achieve quality and efficiency gains.

    • Last Update: 2020-07-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Pharmaceutical Network Market Analysis: The relationship between the pharmaceutical industry and people's livelihood, in order to prevent the frequent occurrence of drug safety problems, in recent years, China has been introducing policies to the industry supply-side reform, to ensure drug safetyfor example, in October 2018, the State Drug Administration issued the Guidance on the Construction of the Retrometric System of Drug Informationization, the Vaccine Law issued in June 2019, and the new version of the Drug Administration Law, all of which call for the establishment of a traceability system for pharmaceutical companies from research and development to production, logistics and consumptionexperts believe that the use of automation, information technology, intelligent solutions is the key way out of quality control and upgrading of pharmaceutical enterprises, but also to complete the production process visualization, equipment operation digital, fine material consumption, environmental monitoring automation and information integration integration of drug quality control objectivesPharmaceutical Equipment (Source: Pharmaceutical Network) Traditional Pharmaceutical Industry needs to be transformed and upgraded towards intelligent manufacturing" At present, pharmaceutical companies should accelerate the transformation and upgrading of the traditional pharmaceutical industry to intelligent manufacturing, and promote the transformation of the pharmaceutical industry to digital, networked and intelligent" industry saidthe author learned that, in fact, in recent years, in the pharmaceutical market competition, belt procurement and other policies frequently issued in the background, reduce the cost, efficiency, quality has become a challenge for pharmaceutical enterprisesat the same time, as the country vigorously promote "Made in China 2025", some pharmaceutical companies have been in the direction of intelligent manufacturing transformation and upgradingfor example, on April 25, Jiuzhitang announced that its "New Model for Integrated Application of Chinese Medicine Solid Stoic Sist Factory" had passed the acceptanceit is learned that Jiuzhitang to six-flavored yellow pills, donkey glue blood particles as a demonstration variety, to build facilities interconnection, system interoperability, data sharing, industry-like mutual ization of Chinese medicine solid formulation intelligent factory integrated application of new models, through the vertical and horizontal integration of the system, to promote the production process of Chinese medicine solids intelligent, to achieve intelligent control of the group, and comprehensively improve the level of intelligent management of enterprisesJiangzhong Group introduced the concept of intelligent manufacturing as early as 2012, and continuously improve the level of production automation and improve product qualityin Jiangtraditionalu Gu liquid preparation workshop, fully enclosed, fully monitored, fully automatic no one is its characteristics, the workshop of large-scale production units in an orderly manner, with the completion of extraction, separation, purification, ingredients, bottle washing, filling, sealing, testing, boxing, palletizing and so on a series of production line processesthe relevant person in charge of pharmaceutical companies said that through the addition of code intelligent manufacturing, pharmaceutical companies automation, digitalization, information technology level will be further improved, production efficiency, product quality will also improvebut at present, the domestic pharmaceutical industry in the new drug research and development, information investment, logistics level and other aspects of the level is still needed to improve, pharmaceutical enterprises smart upgrade, compliance management, quality assurance there is a greater space for improvementstatistics show that more than 4000 pharmaceutical production enterprises in the country, the full use of computer control less than 5%, most enterprises are still using semi-automatic and artificial production technology, resulting in low drug control, it is difficult to make a stable quality of the preparationHow canpharmaceutical companies move towards the transformation and upgrading of intelligent manufacturing? So, how should pharmaceutical companies move towards the transformation and upgrading of intelligent manufacturing? The industry believes that the key to intelligent manufacturing in the pharmaceutical industry lies in the innovation of pharmaceutical equipment and pharmaceutical production processes , in the pharmaceutical industry upstream pharmaceutical equipment, pharmaceutical intelligent manufacturing will be the pharmaceutical equipment flexibility, intelligence and pharmaceutical products life cycle process control put forward higher requirements it is worth noting that with the expansion of the needs of intelligent manufacturing transformation and upgrading of pharmaceutical enterprises, traditional pharmaceutical equipment suppliers have been difficult to meet the needs of enterprises, and with standardized, automation, lean, intelligent pharmaceutical production equipment and overall solutions manufacturers, will be better to help pharmaceutical enterprises intelligent transformation and upgrading at present, the domestic large-scale leading as the representative of the pharmaceutical machine enterprises are promoting the development of pharmaceutical intelligent manufacturing for example, in order to help the development of pharmaceutical intelligent manufacturing, Chutian Technology recently announced that it intends to set up a holding subsidiary of 51 million yuan, the subsidiary will provide bioengineering downstream separation purification of the overall solution and supporting processes, supplies, equipment and pumps, valves and other core devices for the main business company said that the establishment of Chutianyuan is the company's strategic planning of the inevitable measures, around Chutian Technology "one vertical, one platform" development strategy, conducive to promoting the development of pharmaceutical intelligence manufacturing it is understood that Chutian Technology in February 2016 launched the intelligent manufacturing new model project has also recently passed the acceptance the implementation of the project has realized the whole life cycle management of products from research and development, manufacturing, logistics, service, etc., and created a new model of intelligent manufacturing of pharmaceutical equipment and intelligent manufacturing standards, which is conducive to promoting the transformation of China's pharmaceutical equipment enterprises to a new model of intelligent manufacturing in recent years, the company has also gradually set up intelligent sterile disassembly technology product line, intelligent system integration and special assembly technology product line and other technology and product line platform, to create intelligent pharmaceutical production of the overall technology solutions, improve the intelligent level of pharmaceutical production, for the quality and safety of pharmaceutical production to provide a higher level of protection and innovation in the pharmaceutical production process, taking the intelligent manufacturing of Chinese medicine as an example, experts pointed out that by collecting and processing the industrial data in the production process of Chinese medicine, we can better control the fluctuation of the quality of Chinese medicine production, reduce the quality risk, and realize the intelligent manufacturing upgrade of the Chinese medicine industry it is understood that enterprises through the traditional chinese medicine adjustment, cooking methods have been fundamentally changed, the realization of the Chinese medicine manufacturing process standardization, precision improvement, greatly improve the efficacy and pharmaceutical efficiency, but also broke the Chinese medicine production process information island phenomenon, the realization of the whole process of production monitoring, reasonable management and scheduling of various production resources, improve operational efficiency .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.